NTx will be centre stage at the NanoMedicines Innovation Network (NMIN) 2024 Research Conference in Vancouver.

On Thursday, January 24, at 9:15 am PST, Dominik Witzigmann, PhD, NTx Co-founder & CEO will deliver the Industry Keynote: “Next generation LNP technologies for enabling nucleic acid medicines”

On Friday, January 26, at 4:30 pm PST, Pieter Cullis, NTx Co-founder & Board Chair, will deliver the Research Keynote: “The Unlimited Potential of mRNA-Based Gene Therapies – Why Work on Anything Else?”

Daniel Kurek, Senior Scientist, Formulation, and Jessica Silva, Preclinical Immunology Scientist, are presenting a poster on “Long-circulating lipid nanoparticles enhance transfection of hematopoietic stem and progenitor cells in the bone marrow.”

Grishma Pawar, Ph.D, Scientist II in Preclinical, unveils advancements in the “Development of novel and Robust LNP-RNA Vaccines” in her poster.

On Saturday, January 27 at 9:05 am PST, catch NTx CSO, Jayesh Kulkarni, alongside NTx Co-founder Eric Jan and NTx Board Chair Pieter Cullis in a compelling panel discussion of “major problems in development of precise drug delivery systems.”